Phase I/II study of CAR T therapy in patients with B-cell non-Hodgkin lymphomas

Trial Profile

Phase I/II study of CAR T therapy in patients with B-cell non-Hodgkin lymphomas

Planning
Phase of Trial: Phase I/II

Latest Information Update: 20 Sep 2017

At a glance

  • Drugs CAR-T cell therapy-Mustang Bio (Primary)
  • Indications B cell lymphoma
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 Sep 2017 New trial record
    • 15 Sep 2017 According to a Mustang Bio media release, the company expected to initiate this study in the fourth quarter of 2017 and the study will be led by principal investigator Mazyar Shadman.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top